ORIGINAL RESEARCH
Accepted on 21 Apr 2025
Pachymic Acid Alleviates Metabolic Dysfunction-Associated Steatotic Liver Disease by Inhibiting Ferroptosis through PPARα
doi 10.3389/fphar.2025.1554850
- Frontiers in Pharmacology
- Gastrointestinal and Hepatic Pharmacology
- Research Topics
- Metabolic dysfunction and steatotic liver disease
Metabolic dysfunction and steatotic liver disease
356
Total downloads
1,725
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 14 Apr 2025
Mirabegron induces selective changes in the faecal microbiota of HFHFr rats without altering bile acid composition
doi 10.3389/fphar.2025.1547749
- 302 views
ORIGINAL RESEARCH
Published on 05 Mar 2025
Reversed role of CD36 deficiency in high-fat diet or methionine/choline-deficient diet-induced hepatic steatosis and steatohepatitis
doi 10.3389/fphar.2025.1522177
- 643 views
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.